Back

prof. dr. G.D. Valk

prof. dr. G.D. Valk

Full Professor
prof. dr. G.D. Valk
  • Department of Endrocine Oncology

Research Programs

Strategic Program Cancer

Biography

Biography

Endocrinology and endocrine oncology are the main focus of the clinical activities of Gerlof Valk. (Neuro-) endocrine tumors diagnosis, treatment and follow-up, care for patients with Multiple Endocrine Neoplasia (MEN) and the standardization and continuous improvement of the national care for patients with MEN are his specific areas of expertise. Epidemiologic and translational research within the field of MEN related (pancreatic) neuroendocrine tumors is his main research focus including innovative treatment strategies and personalized cancer care.

 

ACADEMIC APPOINTMENTS

2014 – today 

Internist-endocrinologist, professor of endocrinology with emphasis on endocrine tumors, head of section endocrinology, program director endocrinology residency

 

2007 – 2014  

Internist-endocrinologist, vice program director internal medicine residency

 

1997 – 2001  

Senior researcher, Institute for Extramural Medical Research (EMGO Institute), Free University Medical Centre

 

DIPLOMAS AND CERTIFICATION

2007 Certification National Board of Internal Medicine and Endocrinology

2002 MSc Clinical Epidemiology

1997 PhD Thesis: ‘The diagnosing of diabetic polyneuropathy in daily clinical practice’. Free University Medical Centre, Amsterdam

1994 Certification National Board of General Practitioners

1990 MD (cum laude)

 

Side Activities

National coordinator of the European Reference Network (ERN) Rare Endocrine Conditions

Member of the daily board of BijnierNET

Lead of ENETS task force MEN 1

Research Output (209)

Assessing Outcomes After Adrenalectomy for Primary Aldosteronism - Early is Accurate:Retrospective Cohort Study

Suurd Diederik P D, Vorselaars Wessel M C M, Van Beek Dirk-Jan, Borel Rinkes Inne H M, Spiering Wilko, Valk Gerlof D, Vriens Menno R Nov 2022, In: Annals of surgery. 276 , p. 929-934 6 p.

Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs):A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers

Levy Sonja, Arthur James D, Banks Melissa, Kok Niels F M, Fenwick Stephen W, Diaz-Nieto Rafael, van Leerdam Monique E, Cuthbertson Daniel J, Valk Gerlof D, Kuhlmann Koert F D, Tesselaar Margot E T Nov 2022, In: Annals of Surgical Oncology. 29 , p. 7822-7832 11 p.

ASO Visual Abstract:Primary Tumour Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumours (NET)-A Comparison of Upfront Surgical Resection versus a Watch-and-Wait Strategy in Two Specialist NET Centres

Levy Sonja, Arthur James D, Banks Melissa, Kok Niels F M, Fenwick Stephen W, Diaz-Nieto Rafael, van Leerdam Monique E, Cuthbertson Daniel J, Valk Gerlof D, Kuhlmann Koert F D, Tesselaar Margot E T Nov 2022, In: Annals of Surgical Oncology. 29 , p. 7833-7834 2 p.

Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice

van Beek Dirk-Jan, Pieterman Carolina R C, Wessels Frank J, van de Ven Annenienke C, de Herder Wouter W, Dekkers Olaf M, Zandee Wouter T, Drent Madeleine L, Bisschop Peter H, Havekes Bas, Borel Rinkes Inne H M, Vriens Menno R, Valk Gerlof D 7 Oct 2022, In: Frontiers in Endocrinology. 13 , p. 1-12

Update on the clinical management of multiple endocrine neoplasia type 1

Pieterman Carolina R.C., Valk Gerlof D. Oct 2022, In: Clinical Endocrinology. 97 , p. 409-423 15 p.

NETest:serial liquid biopsies in gastroenteropancreatic NET surveillance

van Treijen Mark J.C., Korse Catharina M., Verbeek Wieke H., Tesselaar Margot E.T., Valk Gerlof D. Oct 2022, In: Endocrine connections. 11 12 p.

Four decades of experience with carcinoid heart disease:An analysis of 84 patients

Levy Sonja, Korse Catherina E, de Groot Andre C A, Meijer Ronald C A, Tesselaar Margot E T, Valk Gerlof D 9 Sep 2022, In: Journal of Neuroendocrinology. 34 9 p.

Correction: Lebbink et al. Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span. Cancers 2021, 13, 5104.:Lebbink et al. Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span. (Cancers 2021, 13, 5104)

Lebbink Chantal A, van den Broek Medard F M, Kwast Annemiek B G, Derikx Joep P M, Dierselhuis Miranda P, Kruijff Schelto, Links Thera P, van Trotsenburg A S Paul, Valk Gerlof D, Vriens Menno R, Verrijn Stuart Annemarie A, van Santen Hanneke M, Karim-Kos Henrike E 14 Jun 2022, In: Cancers. 14

Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study

Levy Sonja, Kilgallen Aoife B, Korse Catharina M, Oerlemans Marish I F J, Sluijter Joost P G, van Laake Linda W, Valk Gerlof D, Tesselaar Margot E T 1 May 2022, In: Cancers. 14 , p. 1-13

FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels

Lebbink Chantal A., de Vries Lisa H., Borel Rinkes Inne H.M., Braat Arthur J.A.T., van Leeuwaarde Rachel S., Lodewijk Lutske, van Treijen Mark J.C., Vriens Menno R., Valk Gerlof D., van Santen Hanneke M., de Keizer Bart 1 Apr 2022, In: European Journal of Endocrinology. 187 , p. 101-110 10 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet